Page 2 - Preference Management Solution News Today

Labcorp and MD Anderson Cancer Center Foundation Spain have partnered to boost access to early phase clinical trials in oncology.

Several companies have announced poor results from clinical trials for Alzheimer’s disease therapies this month.

The Government of Victoria in Australia has broken ground on the new $105.4m (A$152m) worth melanoma and clinical trials centre.

Even with academic collaborations, private players are lagging behind public institutions in finding new treatments for opioid addiction.

Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.

Emmes has announced plans to offer data, statistical analysis and project management support for Moderna’s Covid-19 vaccine trial in Africa.

Baili-Biopharmaceutical and AstraZeneca have signed a trial partnership and supply agreement for SI-B001 plus Tagrisso to treat NSCLC.

University of California researchers have developed an app that uses a near-infrared camera to check for neurological disease.

Catalyst Clinical Research acquired Aptus Clinical for expediting expansion to Europe, widening client services and improving patient impact.

France’s pharma industry registered a 7.1% drops in IT hiring activity in March 2022, according to GlobalData